Date & Time: Wednesday, October 13, 2021 | 10:00 am – 11:00 am PDT
Presenters: Prof. Ed Schuuring, and Dr. Darryl Irwin
Hear leading experts discuss the clinical applications of circulating cell free DNA (ccfDNA) in non-small cell lung cancer (NSCLC) patients treated with tyrosine kinase inhibitors or immune checkpoint inhibitors. Complete the form below to register.
Prof. Schuuring and Dr. Irwin will be available to answer questions.
Ed Schuuring, PhD, Professor of Molecular Oncological Pathology at University Medical Center Groningen, Netherlands
Darryl Irwin, PhD, Vice President of Scientific Affairs at Agena Bioscience, Queensland, Australia
Moderator: Bob McGonnagle, Publisher, CAP TODAY